查詢結果分析
相關文獻
- Differential Telomerase Expression and Telomere Length in Primary Intracranial Tumors
- 輻射鋼筋建物居民染色體變異分析評估生物劑量
- X染色體斷裂症候(Fragile X Syndrome)
- 取卵時間與小鼠及家兔卵母細胞第一極體(PB1)形態之完整性和染色體之相對位置之關係
- Pluchea Cass. (Asteraceae: Inuleae) in Taiwan
- Cytological Features of the Aster ageratoides Complex (Asteraceae) in Taiwan
- Sister Chromatid Exchange in Chinese Newborn Infants Treated with Phototherapy for More Than Five Days
- 臺灣錦葵科植物染色體之研究
- 一位懷有染色體異常胎兒高齡初孕婦之不確定感行為
- A Highly Sensitive and Simple Method of Genomic Subtraction
頁籤選單縮合
題 名 | Differential Telomerase Expression and Telomere Length in Primary Intracranial Tumors=腦瘤內遠端酶活性及遠端節長度之差異性 |
---|---|
作 者 | 陳翰容; 卓忠隆; 梁正隆; 陳良; 張學文; 盧康; 李道真; | 書刊名 | 長庚醫學 |
卷 期 | 24:6 2001.06[民90.06] |
頁 次 | 頁352-360 |
分類號 | 415.938 |
關鍵詞 | 染色體; 顱內腫瘤; 遠端酶; 遠端節; Chromosome; Intracranial tumor; Telomerase; Telomere; |
語 文 | 英文(English) |
英文摘要 | Background: Telomerase activity and telomere length have been shown to be involved in controlling cell proliferation and regulating cell senescence. The authors examined telomerase activity and telomere length in intracranial tumors to determine the clinicopathological behavior of primary intracranial tumors with respect to telomerase expression and alteration of telomere length. Methods: Telomerase activity was examined in 139 brain tumor samples. Telomere length was examined in 138 of the 139 samples. These tumors included 61 meningiomas, 27 schwannomas, 19 high-grade neuroepithelial tumors, and 32 low-grade neuroepithelial tumors. Telomerase activity was measured with a telomerase polymerase chain reaction, enzyme-linked immunosolvent assay kit. Telomere length was examined by Southern blot analysis for the terminal restriction fragment length. Results: Telomerase activity was detected in 39.2% (20/51) of the neuroepithelial tumors. Detection rates were 47.4% (9/19) for anaplastic astrocytomas and glioblastomas and 34.4% (11/32) for low-grade neuroepithelial tumors. However, detectable telomerase activity was found in 30.8% (4/13) of atypical or malignant meningiomas, but was not detected in any schwannomas. There was a highly significant difference in the telomerase detection rate in neuroepithelial or non-neuroepithelial tumors (p=0.001). Telomere elongation was found in 11.7% (7/60) of all meningiomas, 46.1% (6/13) of atypical or malignant meningiomas, and 14.8% (4/27) of schwannomas. Elongation of telomere length was detected in 12.6% (11/87) of the cases and 23.5% (12/51) in neuroepithelial tumors. This difference was also significant (p<0.05). Telomere length was reduced in the majority, (75%, 3/4) of malignant or atypical meningiomas with detectable telomerase activity, but only 45% (9/20) of the neuroepithelial tumors. Conclusion: These results indicate that telomerase activation may be a critical step in the pathogenesis of intracranial tumors. Telomere length elongation also indicates a high potential for malignant behavior in these tumors. (Chang Gung Med J 2001;24:352-60) |
本系統中英文摘要資訊取自各篇刊載內容。